Temozolomide, Nedaplatin, Vincristine, and Radiotherapy as First-line Treatment in Newly Diagnosed Primary CNS Lymphoma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01735747
Recruitment Status : Unknown
Verified March 2013 by Rongjie Tao, Shandong Cancer Hospital and Institute.
Recruitment status was:  Active, not recruiting
First Posted : November 28, 2012
Last Update Posted : March 12, 2013
National Natural Science Foundation of China
Information provided by (Responsible Party):
Rongjie Tao, Shandong Cancer Hospital and Institute